- Home
- DCTH vs MOV Comparison
DCTH vs MOV Comparison
Compare DCTH & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- MOV
- Stock Information
- Founded
- DCTH 1988
- MOV 1961
- Country
- DCTH United States
- MOV United States
- Employees
- DCTH N/A
- MOV N/A
- Industry
- DCTH Medical/Dental Instruments
- MOV Consumer Specialties
- Sector
- DCTH Health Care
- MOV Consumer Discretionary
- Exchange
- DCTH Nasdaq
- MOV Nasdaq
- Market Cap
- DCTH 388.3M
- MOV 416.4M
- IPO Year
- DCTH N/A
- MOV 1993
- Fundamental
- Price
- DCTH $9.83
- MOV $18.21
- Analyst Decision
- DCTH Strong Buy
- MOV Strong Buy
- Analyst Count
- DCTH 4
- MOV 1
- Target Price
- DCTH $24.25
- MOV $31.50
- AVG Volume (30 Days)
- DCTH 1.1M
- MOV 103.4K
- Earning Date
- DCTH 11-04-2025
- MOV 12-04-2025
- Dividend Yield
- DCTH N/A
- MOV 7.71%
- EPS Growth
- DCTH N/A
- MOV N/A
- EPS
- DCTH 0.06
- MOV 0.77
- Revenue
- DCTH $70,240,000.00
- MOV $655,597,000.00
- Revenue This Year
- DCTH $146.50
- MOV $1.98
- Revenue Next Year
- DCTH $37.19
- MOV N/A
- P/E Ratio
- DCTH $175.70
- MOV $23.61
- Revenue Growth
- DCTH 491.35
- MOV 0.79
- 52 Week Low
- DCTH $8.87
- MOV $12.85
- 52 Week High
- DCTH $18.23
- MOV $22.20
- Technical
- Relative Strength Index (RSI)
- DCTH 40.06
- MOV 47.00
- Support Level
- DCTH $9.15
- MOV $17.67
- Resistance Level
- DCTH $12.70
- MOV $19.18
- Average True Range (ATR)
- DCTH 0.73
- MOV 0.53
- MACD
- DCTH -0.17
- MOV -0.06
- Stochastic Oscillator
- DCTH 19.16
- MOV 46.68
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.